GSA CAPITAL PARTNERS LLP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$360,000
+35.3%
616,402
+64.7%
0.05%
+50.0%
Q1 2022$266,000
-40.5%
374,276
+10.5%
0.04%
-35.7%
Q4 2021$447,000
-48.1%
338,756
-9.6%
0.06%
-36.4%
Q3 2021$862,000
-57.1%
374,811
+35.6%
0.09%
-73.6%
Q1 2021$2,007,000
+4263.0%
276,381
+2484.0%
0.33%
+4062.5%
Q4 2020$46,000
-2.1%
10,696
-5.7%
0.01%0.0%
Q3 2020$47,000
-62.1%
11,347
-45.2%
0.01%
-88.4%
Q2 2020$124,00020,7070.07%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 2,931,185$12,047,0004.29%
RA Capital Management 12,315,213$50,616,0000.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$28,562,0000.70%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 620,233$2,549,0000.35%
Casdin Capital, LLC 1,870,000$7,686,0000.34%
Vivo Capital, LLC 1,325,736$5,449,0000.32%
Bleichroeder LP 250,000$1,028,0000.18%
Virtus ETF Advisers LLC 40,292$166,0000.09%
Forefront Analytics, LLC 30,369$123,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 411,977$1,693,0000.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders